• Skip to main content

Plain Language Summaries

Standalone, citable summaries published in the Future Science Group journals written to be understood by a lay audience

  • How To Publish
  • How to Write Plain Language Summaries
  • Frequently Asked Questions
  • Publications
    • Animated Videos
    • Bladder, Kidney and Genitals
    • Brain and Nerves
    • Cancer
    • Diabetes and Metabolic Hormones
    • Eyes and Vision
    • Heart and Circulation
    • Infections
    • Inflammatory and Immune-related disorders
    • Mental Health
    • Muscle and Bone
    • Rare Diseases
    • Skin
    • Vaccines
  • Advisory Panel
  • Supporters
  • Blog
  • About Us
  • Contact Us

Sep 15 2022

Osilodrostat for the treatment of Cushing’s disease: a plain language summary of the LINC 4 study

A new plain language summary of publication from Future Rare Diseases discusses the results of the LINC 4 study, which looked at how effective osilodrostat was in patients with Cushing’s disease and what the side effects were.

Read the summary here.

The original article on which this summary is based is called ‘Randomized Trial of Osilodrostat for the Treatment of Cushing Disease’ and was originally published in The Journal of Clinical Endocrinology & Metabolism. The original article can be read here.

  • Share on Twitter Share on Twitter
  • Share on Facebook Share on Facebook
  • Share on LinkedIn Share on LinkedIn

Written by Joanne Walker · Categorized: Diabetes and Metabolic Hormones · Tagged: Cushing's disease, osilodrostat

Copyright © 2023 · Plain Language Summaries · Terms and Conditions · Privacy Policy ·